| scholarly article | Q13442814 |
| P2093 | author name string | Hernández C | |
| Genescà J | |||
| Simó R | |||
| Mesa J | |||
| Jardí R | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| hepatitis C | Q154869 | ||
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 998-1000 | |
| P577 | publication date | 1996-09-01 | |
| P1433 | published in | Diabetes Care | Q5270111 |
| P1476 | title | High prevalence of hepatitis C virus infection in diabetic patients | |
| P478 | volume | 19 |
| Q30250088 | APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing. |
| Q43770083 | Abrupt onset of diabetes during interferon-alpha therapy in patients with chronic hepatitis C. |
| Q37190820 | Application of network construction to estimate functional changes to insulin receptor substrates 1 and 2 in Huh7 cells following infection with the hepatitis C virus |
| Q41653458 | Assessment of evidence for positive association and seroprevalence of hepatitis B and C in diabetic patients in a developing country |
| Q28367308 | Association of chronic hepatitis C virus infection and diabetes mellitus in Korean patients |
| Q35767303 | Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights |
| Q34756492 | Association of diabetes mellitus and chronic hepatitis C virus infection. |
| Q27488739 | Association of hepatitis C virus infection and diabetes in central Tunisia |
| Q47911394 | Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity |
| Q36180921 | Chronic Liver Disease-Associated Hospitalizations Among Adults with Diabetes, National Inpatient Sample, 2001-2012. |
| Q42977737 | Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin |
| Q37370876 | Clinical features of patients with type 2 diabetes mellitus and hepatitis C infection |
| Q33402027 | Community‐based cross‐sectional study: The association of lipids with hepatitis C seropositivity and diabetes mellitus |
| Q36056076 | Diabetes and Hepatitis C: A Two-Way Association |
| Q44678753 | Diabetes mellitus and chronic hepatitis C virus infection |
| Q37084557 | Dysmetabolic changes associated with HCV: a distinct syndrome? |
| Q43520265 | Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha |
| Q35628100 | Fat, diabetes, and liver injury in chronic hepatitis C. |
| Q28079826 | Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV |
| Q36209725 | Glucose intolerance in Chinese patients with chronic hepatitis C. |
| Q56001841 | HEPATITIS C |
| Q37825653 | Hepatic steatosis and hepatitis C: Still unhappy bedfellows? |
| Q33871680 | Hepatitis B and C seroprevalence in patients with diabetes mellitus and its relationship with microvascular complications |
| Q89582866 | Hepatitis C Virus Clearance with Glucose Improvement and Factors Affecting the Glucose Control in Chronic Hepatitis C Patients |
| Q27477554 | Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3 |
| Q37432092 | Hepatitis C and diabetes: the inevitable coincidence? |
| Q37097794 | Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis |
| Q47555610 | Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature |
| Q38190958 | Hepatitis C virus infection and insulin resistance |
| Q26829202 | Hepatitis C virus infection and type 1 and type 2 diabetes mellitus |
| Q42989339 | Hepatitis C virus infection: Review and implications for the dentist |
| Q33363781 | Hepatitis C virus-associated extrahepatic manifestations: a review |
| Q57221072 | Higher Incidence of Diabetes in Liver Transplant Recipients With Hepatitis C |
| Q34722609 | Impact of hepatitis C virus status in pancreas transplantation: a case controlled study |
| Q93934003 | Increased frequency of HCV and HBV infection in type 2 diabetic patients |
| Q82100359 | Insulin resistance in non-diabetic patients with chronic hepatitis C: what does it mean? |
| Q36521105 | Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes. |
| Q44491846 | Low prevalence of hepatitis C virus infection in Greek diabetic patients |
| Q46553728 | Low prevalence of hepatitis-C viral seropositivity among patients with type-2 diabetes mellitus in a tertiary hospital |
| Q79835631 | Mechanisms of glucose intolerance in patients with chronic hepatitis C: implications for treatment |
| Q81721394 | Modification of diabetic retinopathy presentation by underlying hepatitis C infection |
| Q26745576 | NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations |
| Q47592767 | NAFLD/NASH in patients with type 2 diabetes and related treatment options |
| Q36839912 | NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes |
| Q48737910 | Needlestick injuries in European nurses in diabetes |
| Q27488951 | Occurrence of Hepatitis C Virus infection in type 2 diabetic patients attending Plateau state specialist hospital Jos Nigeria |
| Q44934206 | Posttransplant diabetes mellitus in renal transplant patients with hepatitis C virus |
| Q51557818 | Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease |
| Q45729784 | Prevalence of diabetes mellitus in renal transplant patients with hepatitis B or C virus infection |
| Q44571797 | Relationship between iron stores and diabetes mellitus in patients infected by hepatitis C virus: a case-control study |
| Q43034614 | Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. |
| Q34351092 | Seroprevalence of hepatitis C in type 2 diabetes: evidence for a positive association |
| Q41456490 | Seroprevalence of hepatitis C infection in type 2 diabetes mellitus |
| Q37981351 | Synopsis of the WISE meeting |
| Q30870794 | The association of hepatitis C virus infection and post-liver transplant diabetes: data from 17 000 HCV-infected transplant recipients |
| Q37065563 | The effect of hepatitis C virus infection on insulin resistance in chronic haemodialysis patients |
| Q40140184 | The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms |
| Q33801341 | The influence of host factors on the natural history of chronic hepatitis C viral infections |
| Q37887886 | The prevalence and pathogenesis of diabetes mellitus in treated HIV-infection |
| Q37218096 | Transplant-associated hyperglycemia |
| Q38351750 | Type 2 diabetes mellitus and the risk of hepatitis C virus infection: a systematic review |
| Q42990978 | Virus C hepatitis and type 2 diabetes: a cohort study in southern Italy |
| Q36065477 | Viruses and diabetes: is there something sweet about hepatitis C infection? |
| Q37981352 | WISE recommendations to ensure the safety of injections in diabetes |
| Q74209975 | [C virus, iron and sugar] |
| Q73650883 | [Hyperinsulinemia in cirrhotic patients infected with hepatitis C virus] |
Search more.